血清脂联素与CA19-9联合检测对胰腺癌的诊断价值

doi:10.3969/j.issn.1671-7171.2018.11.013

摘要
图/表
参考文献(17)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】研究血清脂联素与19-9 联合检测在胰腺癌诊断中的意义。【方法】检测2016年1月至2018年2月入院的60例胰腺癌患者,90例慢性胰腺炎患者和40例健康人群中CA19-9和脂联素的含量,评价其单独检测和联合检测对于胰腺癌的诊断价值。【结果】与慢性胰腺炎组相比较,胰腺癌组的CA19-9水平显著增高,脂联素水平显著下降。CA19-9和脂联素联合诊断胰腺癌时,其诊断价值高于任一单独指标检测,其灵敏度和特异性分别为88.30%和85.60%。【结论】血清脂联素和 CA19-9 联合检测有利于发现和诊断胰腺癌,提高对胰腺癌的检出率。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	史苇
	谭超超
	谢良伊
	曹友德

关键词 ：胰腺肿瘤/诊断, 脂联素

Abstract：【Objective】To research on the significance of serum adiponectin and CA19-9 joint test in diagnosis of pancreatic cancer.【Methods】The levels of CA19-9 and adiponectin in 60 patients with pancreatic cancer, 90 patients with chronic pancreatitis and 40 healthy people were measured from January 2016 to February 2018 to evaluate the diagnostic value of alone and combined detection for pancreatic cancer to evaluate the diagnostic value of alone and combined detection for pancreatic cancer. 【Result】Compared with the group of chronic pancreatitis, the level of CA19-9 and adiponectin in pancreatic cancer group were significantly increased, and the diagnostic value of CA19-9 combined with adiponectin in the diagnosis of pancreatic cancer was higher than that in any single index. The sensitivity and specificity were 88.30% and 85.60%, respectively.【Conclusion】The combined detection of adiponectin and CA19-9 is helpful for the detection and diagnosis of pancreatic cancer.

Key words： Pancreatic Neoplasms/DI Adiponectin

收稿日期: 2018-05-06

PACS:

R735.9

引用本文:

史苇, 谭超超, 谢良伊, 曹友德. 血清脂联素与CA19-9联合检测对胰腺癌的诊断价值[J]. 医学临床研究, 2018, 35(11): 2118-2120.
SHI Wei, TAN Chao-chao, XIE Liang-yi,et al. Significance of Serum Adiponectin Combined with CA19-9 in the Diagnosis of Pancreatic Cancer. JOURNAL OF CLINICAL RESEARCH, 2018, 35(11): 2118-2120.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2018.11.013 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2018/V35/I11/2118

[1] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J].CA Cancer J Clin,2012,62:10-29.
[2] 颜玉,韩桂桦, 陈刚. 自身免疫性胰腺炎1例[J].黑龙江医药科学, 2013, 36( 5) : 109 -110.
[3] 中华医学会外科学分会胰腺外科学组.慢性胰腺炎诊治指南 (2014年,上海)[J].中华外科杂志2015,53(4):241-243.
[4] Rubenstein JH, Kao JY, Madanick RD,et al.Association of adiponectin multimers with Barrett’s oesophagus[J].Gut,2009,58(12): 1583-1589.
[5] Moon HS. Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans[J].Mol Cancer Ther,2011,10(12):2234-2243.
[6] Moon HS, Liu X. Nagel JM,Chamberland JP,et al. Salutary effects of adiponection on colon cancer: in vivo and in vitro studies in mice[J].Gut, 2013,62(4):561-570.
[7] 宋薇. 膀胱尿路上皮癌患者血清脂联素、瘦素水平及其临床意义[D].兰州大学,2016:1-73.
[8] Grote V A, Rohrmann S, Doossus L,et al.The association of circulating adiponectin levels with pancreatic cancer risk: A study within the prospective EPIC cohort[J].Int J Cancer,2012,130:2428-2437.
[9] Bao Y, Giovannucci E L, Kraft P,et al.A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts[J].J Natl Cancer Inst,2013, 105: 95-103.
[10] Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study[J].Ann Surg,2010, 138(6): 972-976.
[11] 黄丙庆. 脂联素对胰腺癌发展的作用及其机制的研究[J].天津:天津医科大学,2015:1-103.
[12] 沈剑虹, 陆品相. 血清CA199检测对消化道恶性肿瘤的临床意义[J].中国现代医学杂志, 2008, 18(20): 3056-3057.
[13] 陈守庆, 薄维波. CA199、CA242、DKK1联合检测在胰腺癌中的诊断价值[J].国际检验医学杂志,2017. 38(4):496-499.
[14] 巫协宁. 血清CA19-9水平在良、恶性疾病中的变化与意义[J].中华消化杂志, 2012. 32(5):352-355.
[15] 韩贤达, 应晟, 陈志勇.健康体检人群血清CA19-9检验结果分析[J].上海预防医学, 2013, 25(2):109-110.
[16] Guopei Luo, Chen Liu, Meng Guo,et al.Ca19-9-Low&Lewis(+)pancreatic cancer: A unique subtype[J].Cancer Lett,2017.385:46-50.
[17] Steinberg W. The clinical utility of the CA19-9 tumor associate antigen [J].Am J Gastroenterol,1990, 85(4): 350-355.